Shannon Timothy M (CIK 0001207114)

Latest company ownership

ARVN - ARVINAS, INC.
Role: Director
Shares held
679,948
Last filed at
Oct 3, 2018
Confidence Score
50.0
2025Q4
Confidence Score History
2018Q4 2025Q4
Shares held
602,549
Last filed at
May 28, 2019
Confidence Score
50.0
2025Q4
Confidence Score History
2019Q2 2025Q4
NXTC - NextCure, Inc.
Role: Director
Shares held
22,000
Last filed at
Jun 17, 2019
Confidence Score
50.0
2025Q4
Confidence Score History
2019Q2 2025Q4
RLYB - Rallybio Corp
Role: Director
Shares held
6,041
Last filed at
Jan 5, 2022
Confidence Score
50.0
2025Q4
Confidence Score History
2021Q3 2025Q4
Shares held
2,000
Last filed at
Jun 5, 2014
Confidence Score
50.0
2025Q4
Confidence Score History
2010Q3 2025Q4
Shares held
448
Last filed at
Dec 1, 2016
Confidence Score
50.0
2025Q4
Confidence Score History
2016Q2 2025Q4

Recent buy/sell transactions

Exec date Filing date Company Role Signal Confidence Shares % of shares Under plan? Amount (USD)
Sep 3, 2021 Sep 27, 2021 ARVINAS, INC. Director Sell 16.3 -68,798 -3.82% ✗ $6M
Aug 31, 2021 Sep 27, 2021 ARVINAS, INC. Director Sell 15.0 -190,557 -9.56% ✗ $16.4M
Aug 26, 2021 Sep 27, 2021 ARVINAS, INC. Director Sell 16.3 -115,576 -5.48% ✗ $9.9M
Aug 23, 2021 Sep 27, 2021 ARVINAS, INC. Director Sell 17.5 -25,069 -1.17% ✗ $2.2M
Jul 28, 2021 Aug 4, 2021 Rallybio Corp Director Buy 97.5 +2,409,712 100.00% ✗ $1000K
Jun 17, 2020 Jun 19, 2020 ARVINAS, INC. Director Buy 52.5 +2,000 0.04% ✗ $60.5K
Jun 2, 2020 Jun 4, 2020 ARVINAS, INC. Director Buy 60.0 +3,000 0.07% ✗ $96.9K
Mar 20, 2020 Mar 23, 2020 ARVINAS, INC. Director Buy 60.0 +2,500 0.05% ✗ $100K
May 28, 2019 May 28, 2019 IDEAYA Biosciences, Inc. Director Buy 100.0 +400,000 17.69% ✗ $4M
May 13, 2019 May 13, 2019 NextCure, Inc. Director Buy 85.0 +50,000 2.27% ✗ $750K
Mar 28, 2019 Apr 1, 2019 ARVINAS, INC. Director Buy 60.0 +3,500 0.07% ✗ $51.4K
Oct 1, 2018 Oct 3, 2018 ARVINAS, INC. Director Buy 90.0 +4,000 7.78% ✗ $64K
Nov 29, 2016 Dec 1, 2016 CytomX Therapeutics, Inc. Director Sell 32.5 -22,086 -0.68% ✗ $247K
Nov 23, 2016 Nov 28, 2016 CytomX Therapeutics, Inc. Director Sell 20.0 -38,459 -1.04% ✗ $444.4K
Nov 22, 2016 Nov 22, 2016 CytomX Therapeutics, Inc. Director Sell 20.0 -42,550 -1.14% ✗ $498.1K
Nov 17, 2016 Nov 21, 2016 CytomX Therapeutics, Inc. Director Sell 20.0 -45,324 -1.19% ✗ $526.1K
Nov 15, 2016 Nov 16, 2016 CytomX Therapeutics, Inc. Director Sell 20.0 -51,581 -1.34% ✗ $593.4K
Nov 10, 2016 Nov 14, 2016 CytomX Therapeutics, Inc. Director Sell 20.0 -86,270 -2.19% ✗ $962.9K
Nov 9, 2016 Nov 10, 2016 CytomX Therapeutics, Inc. Director Sell 40.0 -13,730 -0.35% ✗ $151.5K
Jun 8, 2016 Jun 10, 2016 CytomX Therapeutics, Inc. Director Sell 20.0 -48,427 -1.13% ✗ $487.5K
Jun 6, 2016 Jun 8, 2016 CytomX Therapeutics, Inc. Director Sell 17.5 -111,498 -2.53% ✗ $1.1M
Jun 2, 2016 Jun 6, 2016 CytomX Therapeutics, Inc. Director Sell 20.0 -59,621 -1.34% ✗ $644K
Jun 1, 2016 Jun 2, 2016 CytomX Therapeutics, Inc. Director Sell 32.5 -22,463 -0.50% ✗ $241.5K
May 27, 2016 Jun 1, 2016 CytomX Therapeutics, Inc. Director Sell 30.0 -25,082 -0.56% ✗ $265.9K
May 25, 2016 May 27, 2016 CytomX Therapeutics, Inc. Director Sell 20.0 -51,343 -1.13% ✗ $530.8K
May 23, 2016 May 25, 2016 CytomX Therapeutics, Inc. Director Sell 40.0 -13,253 -0.29% ✗ $133.7K
May 19, 2016 May 23, 2016 CytomX Therapeutics, Inc. Director Sell 47.5 -8,687 -0.19% ✗ $87.8K
Sep 10, 2010 Sep 13, 2010 Celldex Therapeutics, Inc. Director Buy 91.3 +5,000 100.00% ✗ $17K